HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$8.72
Day range
$8.09 - $8.77
Year range
$5.83 - $26.11
Market cap
350.28M USD
Avg Volume
229.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 5.00M | — |
Operating expense | 11.47M | 162.92% |
Net income | -52.60M | -113.95% |
Net profit margin | -1.05K | — |
Earnings per share | — | — |
EBITDA | -55.59M | -124.62% |
Effective tax rate | -0.82% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 350.77M | 516.93% |
Total assets | 369.97M | 442.63% |
Total liabilities | 57.51M | 31.26% |
Total equity | 312.46M | — |
Shares outstanding | 41.80M | — |
Price to book | 1.17 | — |
Return on assets | -35.96% | — |
Return on capital | -41.31% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -52.60M | -113.95% |
Cash from operations | -38.55M | -150.35% |
Cash from investing | -3.74M | -21,870.59% |
Cash from financing | 1.85M | 3,606.00% |
Net change in cash | -40.30M | -160.74% |
Free cash flow | -17.53M | -237.61% |
About
Founded
2019
Headquarters
Website
Employees
130